Atlas Trials

A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability

Clinical trial NCT04735822 · COMPLETED

Trial details

NCT number
NCT04735822
Sponsor
Kadmon Corporation, LLC
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2020-10-26
Primary completion
2021-09-03
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.